Sex differences and central protective effect of 17β-estradiol in the development of aldosterone/NaCl-induced hypertension

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 296, Issue 5, 2009, Pages

  Xue, Baojian ^a   Badaue Passos Jr , Daniel ^a   Guo, Fang ^a   Gomez Sanchez, Celso E ^d   Hay, Meredith ^e   Johnson, Alan Kim ^a,b,c  

^a University of Iowa   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^e UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Blood pressure; Estrogen receptor; Heart rate; Sympathetic nervous system

Indexed keywords

ALDOSTERONE; ESTRADIOL; ESTRADIOL RECEPTOR; FULVESTRANT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CASTRATED MALE; CONTROLLED STUDY; FEMALE; GANGLION BLOCK; GONADECTOMY; HEART RATE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SALT INTAKE; SEX DIFFERENCE; THALAMUS MIDLINE NUCLEUS;

ADMINISTRATION, ORAL; ALDOSTERONE; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; BRAIN; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; GANGLIONIC BLOCKERS; HEART RATE; HEXAMETHONIUM; HYPERTENSION; INFUSION PUMPS, IMPLANTABLE; MALE; ORCHIECTOMY; OVARIECTOMY; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; SEX FACTORS; SODIUM CHLORIDE; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS;

EID: 66149149718     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01255.2008     Document Type: Article

References (48)

1. Ahima R, Krozowski Z, Harlan R. Type I corticosteroid receptor-like immunoreactivity in the rat CNS: distribution and regulation by corticosteroids. J Comp Neurol 313: 522-538, 1991.
2. Arias-Loza PA, Hu K, Dienesch C, Mehlich AM, Konig S, Jazbutyte V, Neyses L, Hegele-Hartung C, Heinrich Fritzemeier K, Pelzer T. Both estrogen receptor subtypes, alpha and beta, attenuate cardiovascular remodeling in aldosterone salt-treated rats. Hypertension 50: 432-438, 2007. (Pubitemid 47205796)
3. Arias-Loza PA, Hu K, Schafer A, Bauersachs J, Quaschning T, Galle J, Jazbutyte V, Neyses L, Ertl G, Fritzemeier KH, Hegele-Hartung C, Pelzer T. Medroxyprogesterone acetate but not drospirenone ablates the protective function of 17 beta-estradiol in aldosterone salt-treated rats. Hypertension 48: 994-1001, 2006. (Pubitemid 44611015)
4. Burgess LH, Handa RJ. Estrogen-induced alterations in the regulation of mineralocorticoid and glucocorticoid receptor messenger RNA expression in the female rat anterior pituitary gland and brain. Mol Cell Neurosci 4: 191-198, 1993.
5. Castren M, Patchev VK, Almeida OF, Holsboer F, Trapp T, Castren E. Regulation of rat mineralocorticoid receptor expression in neurons by progesterone. Endocrinology 136: 3800-3806, 1995.
6. Ciriello J. Afferent renal inputs to paraventricular nucleus vasopressin and oxytocin neurosecretory neurons. Am J Physiol Regul Integr Comp Physiol 275: R1745-R1754, 1998. (Pubitemid 128731603)
7. Conlin PR. Interactions of high salt intake and the response of the cardiovascular system to aldosterone. Cardiol Rev 13: 118-124, 2005.
8. Connell JM, Davis E. The new biology of aldosterone. J Endocrinol 186: 1-20, 2005.
9. Crofton JT, Share L. Gonadal hormones modulate deoxycorticosterone-salt hypertension in male and female rats. Hypertension 29: 494-499, 1997. (Pubitemid 27074089)
10. De Kloet ER, Van Acker SA, Sibug RM, Oitzl MS, Meijer OC, Rahmouni K, de Jong W. Brain mineralocorticoid receptors and centrally regulated functions. Kidney Int 57: 1329-1336, 2000. (Pubitemid 30207887)
11. Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res 53: 688-708, 2002. (Pubitemid 34175262)
12. Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 53: 672-677, 2002. (Pubitemid 34175260)
13. Gingerich S, Krukoff TL. Estrogen in the paraventricular nucleus attenuates L-glutamate-induced increases in mean arterial pressure through estrogen receptor beta and NO. Hypertension 48: 1130-1136, 2006.
14. Gomez-Sanchez EP. Central hypertensive effects of aldosterone. Front Neuroendocrinol 18: 440-462, 1997.
15. Gomez-Sanchez EP. Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology 118: 819-823, 1986.
16. Gomez-Sanchez EP, Fort CM, Gomez-Sanchez CE. Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension. Am J Physiol Endocrinol Metab 258: E482-E484, 1990.
17. Han F, Ozawa H, Matsuda K, Nishi M, Kawata M. Colocalization of mineralocorticoid receptor and glucocorticoid receptor in the hippocampus and hypothalamus. Neurosci Res 51: 371-381, 2005. (Pubitemid 40299325)
18. Hegele-Hartung C, Siebel P, Peters O, Kosemund D, Müller G, Hillisch A, Walter A, Kraetzschmar J, Fritzemeier KH. Impact of isotype-selective estrogen receptor agonists on ovarian function. Proc Natl Acad Sci USA 101: 5129-5134, 2004. (Pubitemid 38476910)
19. Huang BS, Wang H, Leenen FH. Chronic central infusion of aldosterone leads to sympathetic hyperreactivity and hypertension in Dahl S but not Dahl R rats. Am J Physiol Heart Circ Physiol 288: H517-H524, 2005. (Pubitemid 40139633)
20. Janiak PC, Lewis SJ, Brody MJ. Role of central mineralocorticoid binding sites in development of hypertension. Am J Physiol Regul Integr Comp Physiol 259: R1025-R1034, 1990.
21. Jazbutyte V, Arias-Loza PA, Hu K, Widder J, Govindaraj V, von Poser-Klein C, Bauersachs J, Fritzemeier KH, Hegele-Hartung C, Neyses L, Ertl G, Pelzer T. Ligand-dependent activation of ERβ lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats. Cardiovasc Res 77: 774-781, 2008.
22. Johnson AK, Gross PM. Sensory circumventricular organs and brain homeostatic pathways. FASEB J 7: 678-686, 1993.
23. Kageyama Y, Bravo EL. Hypertensive mechanisms associated with centrally administered aldosterone in dogs. Hypertension 11: 750-753, 1988. (Pubitemid 18189603)
24. Kanagy NL, Pawloski CM, Fink GD. Role of aldosterone in angiotensin II-induced hypertension in rats. Am J Physiol Regul Integr Comp Physiol 259: R102-R109, 1990.
25. Li DP, Chen SR, Pan HL. Angiotensin II stimulates spinally projecting paraventricular neurons through presynaptic disinhibition. J Neurosci 23: 5041-5049, 2003.
26. Li Z, Hay M. 17-Beta-estradiol modulation of area postrema potassium currents. J Neurophysiol 84: 1385-1391, 2000.
27. Obst M, Gross V, Luft FC. Systemic hemodynamics in non-anesthetized L-NAME and DOCA-salt-treated mice. J Hypertens 22: 1889-1894, 2004. (Pubitemid 39336671)
28. Osborn JW, Jacob F, Hendel M, Collister JP, Clark L, Guzman PA. Effect of subfornical organ lesion on the development of mineralocorticoid- salt hypertension. Brain Res 1109: 74-82, 2006. (Pubitemid 44403972)
29. Osterlund M, Kuiper GG, Gustafsson JA, Hurd YL. Differential distribution and regulation of estrogen receptor-alpha and -beta mRNA within the female rat brain. Brain Res Mol Brain Res 54: 175-180, 1998. (Pubitemid 28119175)
30. Ouchi Y, Share L, Crofton JT, Iitake K, Brooks DP. Sex difference in pressor responsiveness to vasopressin and baroreflex function in DOC-salt hypertensive rats. J Hypertens 6: 381-387, 1988. (Pubitemid 18167931)
31. Pamidimukkala J, Hay M. 17β-Estradiol inhibits angiotensin II activation of area postrema neurons. Am J Physiol Heart Circ Physiol 285: H1515-H1520, 2003. (Pubitemid 37169505)
32. Peysner K, Henry CA, Malvin RL. Central infusion of aldosterone increases blood pressure by mechanisms independent of Na retention. Clin Exp Hypertens A 12: 399-414, 1990. (Pubitemid 20192586)
33. Pyner S, Coote JH. Identification of branching paraventricular neurons of the hypothalamus that project to the rostroventrolateral medulla and spinal cord. Neuroscience 100: 549-556, 2000.
34. Schunkert H, Hense HW, Muscholl M, Luchner A, Kurzinger S, Danser AH, Riegger GA. Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass. Heart 77: 24-31, 1997. (Pubitemid 27076910)
35. Shughrue PJ, Merchenthaler I. Distribution of estrogen receptor beta immunoreactivity in the rat central nervous system. J Comp Neurol 436: 64-81, 2001.
36. Stowasser M, Bachmann AW, Huggard PR, Rossetti TR, Gordon RD. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance. J Clin Endocrinol Metab 85: 2160-2166, 2000. (Pubitemid 32269238)
37. Struthers AD. The clinical implications of aldosterone escape in congestive heart failure. Eur J Heart Fail 6: 539-545, 2004.
38. Turner BB. Influence of gonadal steroids on brain corticosteroid receptors: a minireview. Neurochem Res 22: 1375-1385, 1997.
39. Vasan RS, Evans JC, Benjamin EJ, Levy D, Larson MG, Sundstrom J, Murabito JM, Sam F, Colucci WS, Wilson PW. Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart Study. Hypertension 43: 957-962, 2004. (Pubitemid 38579898)
40. Wang H, Huang BS, Leenen FH. Brain sodium channels and ouabainlike compounds mediate central aldosterone-induced hypertension. Am J Physiol Heart Circ Physiol 285: H2516-H2523, 2003. (Pubitemid 37443069)
41. White WB. Drospirenone with 17β-estradiol in the postmenopausal woman with hypertension. Climacteric 10 Suppl 1: 25-31, 2007.
42. White WB, Hanes V, Chauhan V, Pitt B. Effects of a new hormone therapy, drospirenone and 17-beta-estradiol, in postmenopausal women with hypertension. Hypertension 48: 246-253, 2006. (Pubitemid 44309819)
43. Xue B, Badaue-Passos D Jr, Beltz TG, Johnson RF, Johnson AK, Hay M. Central injections of adeno-associated virus-siRNA gene to silence estrogen receptor beta (ERβ) augment aldosterone-induced hypertension in female rats (Abstract). FASEB J 22: 737.35, 2008.
44. Xue B, Pamidimukkala J, Lubahn DB, Hay M. Estrogen receptor-α mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice. Am J Physiol Heart Circ Physiol 292: H1770-H1776, 2007. (Pubitemid 46572400)
45. Xue B, Zhao Y, Johnson AK, Hay M. Central estrogen inhibition of angiotensin II-induced hypertension in male mice and the role of reactive oxygen species. Am J Physiol Heart Circ Physiol 295: H1025-H1032, 2008.
46. Yoshimoto T, Hirata Y. Aldosterone as a cardiovascular risk hormone. Endocr J 54: 359-370, 2007.
47. Zhang ZH, Kang YM, Yu Y, Wei SG, Schmidt TJ, Johnson AK, Felder RB. 11β-Hydroxysteroid dehydrogenase type 2 activity in hypothalamic paraventricular nucleus modulates sympathetic excitation. Hypertension 48: 127-133, 2006. (Pubitemid 44297534)
48. Zhang ZH, Yu Y, Kang YM, Wei SG, Felder RB. Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats. Am J Physiol Heart Circ Physiol 294: H1067-H1074, 2008.